Integrated control of cancer stemness by σ1 receptor in advanced prostate cancer.
Saved in:
| Title: | Integrated control of cancer stemness by σ |
|---|---|
| Authors: | Civenni G; Institute of Oncology Research (IOR), Università della Svizzera italiana (USI), Bellinzona, Switzerland., Sandrini G; Institute of Oncology Research (IOR), Università della Svizzera italiana (USI), Bellinzona, Switzerland.; Bioinformatics Core Unit, Institute of Oncology Research (IOR) and Swiss Institute of Bioinformatics, Bellinzona, Switzerland., Merulla J; Institute of Oncology Research (IOR), Università della Svizzera italiana (USI), Bellinzona, Switzerland., Musumeci C; Institute of Oncology Research (IOR), Università della Svizzera italiana (USI), Bellinzona, Switzerland., Federici E; Institute of Oncology Research (IOR), Università della Svizzera italiana (USI), Bellinzona, Switzerland., Vallegra A; Mario Negri Institute for Pharmacological Research, Milano, Italy., Kokanovic A; Institute of Oncology Research (IOR), Università della Svizzera italiana (USI), Bellinzona, Switzerland., Mosole S; Institute of Oncology Research (IOR), Università della Svizzera italiana (USI), Bellinzona, Switzerland., Shinde D; Institute of Oncology Research (IOR), Università della Svizzera italiana (USI), Bellinzona, Switzerland., Sorrenti E; Institute of Oncology Research (IOR), Università della Svizzera italiana (USI), Bellinzona, Switzerland., Paganoni AJJ; Institute of Oncology Research (IOR), Università della Svizzera italiana (USI), Bellinzona, Switzerland., Marchetti M; Institute of Oncology Research (IOR), Università della Svizzera italiana (USI), Bellinzona, Switzerland., Valzelli R; Institute of Oncology Research (IOR), Università della Svizzera italiana (USI), Bellinzona, Switzerland., Albino D; Institute of Oncology Research (IOR), Università della Svizzera italiana (USI), Bellinzona, Switzerland., Pecoraro M; Institute for Research in Biomedicine (IRB), Università della Svizzera italiana (USI), Bellinzona, Switzerland., Rinaldi A; Institute of Oncology Research (IOR), Università della Svizzera italiana (USI), Bellinzona, Switzerland., Bolis M; Institute of Oncology Research (IOR), Università della Svizzera italiana (USI), Bellinzona, Switzerland.; Bioinformatics Core Unit, Institute of Oncology Research (IOR) and Swiss Institute of Bioinformatics, Bellinzona, Switzerland.; Mario Negri Institute for Pharmacological Research, Milano, Italy., Geiger R; Institute of Oncology Research (IOR), Università della Svizzera italiana (USI), Bellinzona, Switzerland.; Institute for Research in Biomedicine (IRB), Università della Svizzera italiana (USI), Bellinzona, Switzerland., Winge T; Institut für Pharmazeutische und Medizinische Chemie, Westfälische Wilhelms-Universität Münster, Münster, Germany., Holtschulte C; Institut für Pharmazeutische und Medizinische Chemie, Westfälische Wilhelms-Universität Münster, Münster, Germany., Laurini E; Molecular Biology and Nanotechnology Laboratory (MolBNL@UniTS), DEA, University of Trieste, Trieste, Italy., Pricl S; Molecular Biology and Nanotechnology Laboratory (MolBNL@UniTS), DEA, University of Trieste, Trieste, Italy., Carbone GM; Institute of Oncology Research (IOR), Università della Svizzera italiana (USI), Bellinzona, Switzerland., Wünsch B; Institut für Pharmazeutische und Medizinische Chemie, Westfälische Wilhelms-Universität Münster, Münster, Germany., Catapano CV; Institute of Oncology Research (IOR), Università della Svizzera italiana (USI), Bellinzona, Switzerland. carlo.catapano@ior.usi.ch. |
| Source: | Oncogene [Oncogene] 2025 Nov; Vol. 44 (42), pp. 4032-4046. Date of Electronic Publication: 2025 Sep 02. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8711562 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5594 (Electronic) Linking ISSN: 09509232 NLM ISO Abbreviation: Oncogene Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40897798 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Integrated control of cancer stemness by σ<subscript>1</subscript> receptor in advanced prostate cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Civenni+G%22">Civenni G</searchLink>; Institute of Oncology Research (IOR), Università della Svizzera italiana (USI), Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Sandrini+G%22">Sandrini G</searchLink>; Institute of Oncology Research (IOR), Università della Svizzera italiana (USI), Bellinzona, Switzerland.; Bioinformatics Core Unit, Institute of Oncology Research (IOR) and Swiss Institute of Bioinformatics, Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Merulla+J%22">Merulla J</searchLink>; Institute of Oncology Research (IOR), Università della Svizzera italiana (USI), Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Musumeci+C%22">Musumeci C</searchLink>; Institute of Oncology Research (IOR), Università della Svizzera italiana (USI), Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Federici+E%22">Federici E</searchLink>; Institute of Oncology Research (IOR), Università della Svizzera italiana (USI), Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Vallegra+A%22">Vallegra A</searchLink>; Mario Negri Institute for Pharmacological Research, Milano, Italy.<br /><searchLink fieldCode="AU" term="%22Kokanovic+A%22">Kokanovic A</searchLink>; Institute of Oncology Research (IOR), Università della Svizzera italiana (USI), Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Mosole+S%22">Mosole S</searchLink>; Institute of Oncology Research (IOR), Università della Svizzera italiana (USI), Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Shinde+D%22">Shinde D</searchLink>; Institute of Oncology Research (IOR), Università della Svizzera italiana (USI), Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Sorrenti+E%22">Sorrenti E</searchLink>; Institute of Oncology Research (IOR), Università della Svizzera italiana (USI), Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Paganoni+AJJ%22">Paganoni AJJ</searchLink>; Institute of Oncology Research (IOR), Università della Svizzera italiana (USI), Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Marchetti+M%22">Marchetti M</searchLink>; Institute of Oncology Research (IOR), Università della Svizzera italiana (USI), Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Valzelli+R%22">Valzelli R</searchLink>; Institute of Oncology Research (IOR), Università della Svizzera italiana (USI), Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Albino+D%22">Albino D</searchLink>; Institute of Oncology Research (IOR), Università della Svizzera italiana (USI), Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Pecoraro+M%22">Pecoraro M</searchLink>; Institute for Research in Biomedicine (IRB), Università della Svizzera italiana (USI), Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Rinaldi+A%22">Rinaldi A</searchLink>; Institute of Oncology Research (IOR), Università della Svizzera italiana (USI), Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Bolis+M%22">Bolis M</searchLink>; Institute of Oncology Research (IOR), Università della Svizzera italiana (USI), Bellinzona, Switzerland.; Bioinformatics Core Unit, Institute of Oncology Research (IOR) and Swiss Institute of Bioinformatics, Bellinzona, Switzerland.; Mario Negri Institute for Pharmacological Research, Milano, Italy.<br /><searchLink fieldCode="AU" term="%22Geiger+R%22">Geiger R</searchLink>; Institute of Oncology Research (IOR), Università della Svizzera italiana (USI), Bellinzona, Switzerland.; Institute for Research in Biomedicine (IRB), Università della Svizzera italiana (USI), Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Winge+T%22">Winge T</searchLink>; Institut für Pharmazeutische und Medizinische Chemie, Westfälische Wilhelms-Universität Münster, Münster, Germany.<br /><searchLink fieldCode="AU" term="%22Holtschulte+C%22">Holtschulte C</searchLink>; Institut für Pharmazeutische und Medizinische Chemie, Westfälische Wilhelms-Universität Münster, Münster, Germany.<br /><searchLink fieldCode="AU" term="%22Laurini+E%22">Laurini E</searchLink>; Molecular Biology and Nanotechnology Laboratory (MolBNL@UniTS), DEA, University of Trieste, Trieste, Italy.<br /><searchLink fieldCode="AU" term="%22Pricl+S%22">Pricl S</searchLink>; Molecular Biology and Nanotechnology Laboratory (MolBNL@UniTS), DEA, University of Trieste, Trieste, Italy.<br /><searchLink fieldCode="AU" term="%22Carbone+GM%22">Carbone GM</searchLink>; Institute of Oncology Research (IOR), Università della Svizzera italiana (USI), Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Wünsch+B%22">Wünsch B</searchLink>; Institut für Pharmazeutische und Medizinische Chemie, Westfälische Wilhelms-Universität Münster, Münster, Germany.<br /><searchLink fieldCode="AU" term="%22Catapano+CV%22">Catapano CV</searchLink>; Institute of Oncology Research (IOR), Università della Svizzera italiana (USI), Bellinzona, Switzerland. carlo.catapano@ior.usi.ch. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228711562%22">Oncogene</searchLink> [Oncogene] 2025 Nov; Vol. 44 (42), pp. 4032-4046. <i>Date of Electronic Publication: </i>2025 Sep 02. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%22">Nature Publishing Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>8711562 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1476-5594 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209509232%22">09509232 </searchLink><i>NLM ISO Abbreviation: </i>Oncogene <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40897798 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41388-025-03541-7 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 4032 Titles: – TitleFull: Integrated control of cancer stemness by σ1 receptor in advanced prostate cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Civenni G – PersonEntity: Name: NameFull: Sandrini G – PersonEntity: Name: NameFull: Merulla J – PersonEntity: Name: NameFull: Musumeci C – PersonEntity: Name: NameFull: Federici E – PersonEntity: Name: NameFull: Vallegra A – PersonEntity: Name: NameFull: Kokanovic A – PersonEntity: Name: NameFull: Mosole S – PersonEntity: Name: NameFull: Shinde D – PersonEntity: Name: NameFull: Sorrenti E – PersonEntity: Name: NameFull: Paganoni AJJ – PersonEntity: Name: NameFull: Marchetti M – PersonEntity: Name: NameFull: Valzelli R – PersonEntity: Name: NameFull: Albino D – PersonEntity: Name: NameFull: Pecoraro M – PersonEntity: Name: NameFull: Rinaldi A – PersonEntity: Name: NameFull: Bolis M – PersonEntity: Name: NameFull: Geiger R – PersonEntity: Name: NameFull: Winge T – PersonEntity: Name: NameFull: Holtschulte C – PersonEntity: Name: NameFull: Laurini E – PersonEntity: Name: NameFull: Pricl S – PersonEntity: Name: NameFull: Carbone GM – PersonEntity: Name: NameFull: Wünsch B – PersonEntity: Name: NameFull: Catapano CV IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 11 Text: 2025 Nov Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1476-5594 Numbering: – Type: volume Value: 44 – Type: issue Value: 42 Titles: – TitleFull: Oncogene Type: main |
| ResultId | 1 |